Cardiovascular drug, any agent that affects the function of the heart and blood vessels. Drugs that act on the cardiovascular system are among the most widely used in medicine.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Cardiovascular Drug industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
heparin
Coumadin
Sectral
Zebeta
Lopressor
Toprol XL
Norvasc
Lotrel
Market Segment by Product Application
Hospital
Clinic
Others
Finally, the report provides detailed profile and data information analysis of leading company.
Amgen
AstraZeneca
Bayer
Bristol Myers Squibb and Pfizer
Daiichi Sankyo
Johnson & Johnson
Merck & Co.
Novartis
Pfizer
Portola
Sanofi
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Cardiovascular Drug consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Cardiovascular Drug market by identifying its various subsegments.
3.Focuses on the key global Cardiovascular Drug manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Cardiovascular Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Cardiovascular Drug submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Cardiovascular Drug Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Cardiovascular Drug Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Cardiovascular Drug Segment by Type
2.1.1 heparin
2.1.2 Coumadin
2.1.3 Sectral
2.1.4 Zebeta
2.1.5 Lopressor
2.1.6 Toprol XL
2.1.7 Norvasc
2.1.8 Lotrel
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Others
2.3 Global Cardiovascular Drug Market Comparison by Regions (2017-2027)
2.3.1 Global Cardiovascular Drug Market Size (2017-2027)
2.3.2 North America Cardiovascular Drug Status and Prospect (2017-2027)
2.3.3 Europe Cardiovascular Drug Status and Prospect (2017-2027)
2.3.4 China Cardiovascular Drug Status and Prospect (2017-2027)
2.3.5 Japan Cardiovascular Drug Status and Prospect (2017-2027)
2.3.6 Southeast Asia Cardiovascular Drug Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Cardiovascular Drug Industry Impact
2.5.1 Cardiovascular Drug Business Impact Assessment - Covid-19
2.5.2 Market Trends and Cardiovascular Drug Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Cardiovascular Drug Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Cardiovascular Drug Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Cardiovascular Drug Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Cardiovascular Drug Manufacturer Market Share
3.5 Top 10 Cardiovascular Drug Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Cardiovascular Drug Market
3.7 Key Manufacturers Cardiovascular Drug Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Cardiovascular Drug Industry Key Manufacturers
4.1 Amgen
4.1.1 Compan Detail
4.1.2 Amgen Cardiovascular Drug Product Introduction, Application and Specification
4.1.3 Amgen 162 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Amgen News
4.2 AstraZeneca
4.2.1 Compan Detail
4.2.2 AstraZeneca Cardiovascular Drug Product Introduction, Application and Specification
4.2.3 AstraZeneca Cardiovascular Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Amgen News
4.3 Bayer
4.3.1 Compan Detail
4.3.2 Bayer Cardiovascular Drug Product Introduction, Application and Specification
4.3.3 Bayer Cardiovascular Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Bayer News
4.4 Bristol Myers Squibb and Pfizer
4.4.1 Compan Detail
4.4.2 Bristol Myers Squibb and Pfizer Cardiovascular Drug Product Introduction, Application and Specification
4.4.3 Bristol Myers Squibb and Pfizer Cardiovascular Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Bristol Myers Squibb and Pfizer News
4.5 Daiichi Sankyo
4.5.1 Compan Detail
4.5.2 Bristol Myers Squibb and Pfizer Cardiovascular Drug Product Introduction, Application and Specification
4.5.3 Daiichi Sankyo Cardiovascular Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Daiichi Sankyo News
4.6 Johnson & Johnson
4.6.1 Compan Detail
4.6.2 Johnson & Johnson Cardiovascular Drug Product Introduction, Application and Specification
4.6.3 Johnson & Johnson Cardiovascular Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Johnson & Johnson News
4.7 Merck & Co.
4.7.1 Compan Detail
4.7.2 Merck & Co. Cardiovascular Drug Product Introduction, Application and Specification
4.7.3 Merck & Co. Cardiovascular Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Novartis
4.8.1 Compan Detail
4.8.2 Novartis Cardiovascular Drug Product Introduction, Application and Specification
4.8.3 Novartis Cardiovascular Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Novartis News
4.9 Pfizer
4.9.1 Compan Detail
4.9.2 Pfizer Cardiovascular Drug Product Introduction, Application and Specification
4.9.3 Pfizer Cardiovascular Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Pfizer News
4.10 Portola
4.10.1 Compan Detail
4.10.2 Portola Cardiovascular Drug Product Introduction, Application and Specification
4.10.3 Portola Cardiovascular Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Portola News
4.11 Sanofi
4.11.1 Compan Detail
4.11.2 Sanofi Cardiovascular Drug Product Introduction, Application and Specification
4.11.3 Sanofi Cardiovascular Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Sanofi News
5 Global Cardiovascular Drug Market Segment by Big Type
5.1 Global Cardiovascular Drug Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Cardiovascular Drug Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Cardiovascular Drug Revenue and Market Share by Big Type (2017-2022)
5.2 heparin Sales Growth Rate and Price
5.2.1 Global heparin Sales Growth Rate (2017-2022)
5.2.2 Global heparin Price (2017-2022)
5.3 Coumadin Sales Growth Rate and Price
5.3.1 Global Coumadin Sales Growth Rate (2017-2022)
5.3.2 Global Coumadin Price (2017-2022)
5.4 Sectral Sales Growth Rate and Price
5.4.1 Global Sectral Sales Growth Rate (2017-2022)
5.4.2 Global Sectral Price (2017-2022)
5.5 Zebeta Sales Growth Rate and Price
5.5.1 Global Zebeta Sales Growth Rate (2017-2022)
5.5.2 Global Zebeta Price (2017-2022)
5.6 Lopressor Sales Growth Rate and Price
5.6.1 Global Lopressor Sales Growth Rate (2017-2022)
5.6.2 Global Lopressor Price (2017-2022)
5.7 Toprol XL Sales Growth Rate and Price
5.7.1 Global Toprol XL Sales Growth Rate (2017-2022)
5.7.2 Global Toprol XL Price (2017-2022)
5.8 Norvasc Sales Growth Rate and Price
5.8.1 Global Norvasc Sales Growth Rate (2017-2022)
5.8.2 Global Norvasc Price (2017-2022)
5.9 Lotrel Sales Growth Rate and Price
5.9.1 Global Lotrel Sales Growth Rate (2017-2022)
5.9.2 Global Lotrel Price (2017-2022)
6 Global Cardiovascular Drug Market Segment by Big Application
6.1 Global Cardiovascular Drug Sales Market Share by Big Application (2017-2022)
6.2 Hospital Sales Growth Rate (2017-2022)
6.3 Clinic Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Cardiovascular Drug Forecast
7.1 Global Cardiovascular Drug Revenue, Sales and Growth Rate (2022-2027)
7.2 Cardiovascular Drug Market Forecast by Regions (2022-2027)
7.2.1 North America Cardiovascular Drug Market Forecast (2022-2027)
7.2.2 Europe Cardiovascular Drug Market Forecast (2022-2027)
7.2.3 China Cardiovascular Drug Market Forecast (2022-2027)
7.2.4 Japan Cardiovascular Drug Market Forecast (2022-2027)
7.2.5 Southeast Asia Cardiovascular Drug Market Forecast (2022-2027)
7.2.6 Other Regions Cardiovascular Drug Market Forecast (2022-2027)
7.3 Cardiovascular Drug Market Forecast by Type (2022-2027)
7.3.1 Global Cardiovascular Drug Sales Forecast by Type (2022-2027)
7.3.2 Global Cardiovascular Drug Market Share Forecast by Type (2022-2027)
7.4 Cardiovascular Drug Market Forecast by Application (2022-2027)
7.4.1 Global Cardiovascular Drug Sales Forecast by Application (2022-2027)
7.4.2 Global Cardiovascular Drug Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Cardiovascular Drug Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Cardiovascular Drug Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Cardiovascular Drug
Figure Market Concentration Ratio and Market Maturity Analysis of Cardiovascular Drug
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Cardiovascular Drug Market Size by Big Type
Figure Global Market Share of Cardiovascular Drug by Big Type in 2021
Figure heparin Picture (2017-2022)
Figure Coumadin Picture (2017-2022)
Figure Sectral Picture (2017-2022)
Figure Zebeta Picture (2017-2022)
Figure Lopressor Picture (2017-2022)
Figure Toprol XL Picture (2017-2022)
Figure Norvasc Picture (2017-2022)
Global Cardiovascular Drug Market Size by Big Application
Table Global Cardiovascular Drug Market Size by Application
Figure Global Cardiovascular Drug Market Share by Big Application in 2021
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Table Global Cardiovascular Drug Comparison by Regions (M USD) ?2017-2027?
Figure Global Cardiovascular Drug Market Size (Million US$) (2017-2027)
Figure North America Cardiovascular Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Cardiovascular Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure China Cardiovascular Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Cardiovascular Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Cardiovascular Drug Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Cardiovascular Drug Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Cardiovascular Drug Sales by Manufacturer (2017-2022)
Figure Global Cardiovascular Drug Sales Market Share by Manufacturer in 2021
Table Global Cardiovascular Drug Revenue by Manufacturer (2017-2022)
Figure Global Cardiovascular Drug Revenue Market Share by Manufacturer in 2021
Table Global Cardiovascular Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Cardiovascular Drug Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Cardiovascular Drug Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Cardiovascular Drug Market
Table Key Manufacturers Cardiovascular Drug Product Type
Table Mergers & Acquisitions Planning
Table Amgen Company Profile
Table Cardiovascular Drug Product Introduction, Application and Specification of Amgen
Table Cardiovascular Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table AstraZeneca Company Profile
Table Cardiovascular Drug Product Introduction, Application and Specification of AstraZeneca
Table Cardiovascular Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca Recent Development
Table Bayer Company Profile
Table Cardiovascular Drug Product Introduction, Application and Specification of Bayer
Table Cardiovascular Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer Main Business
Table Bayer Recent Development
Table Bristol Myers Squibb and Pfizer Company Profile
Table Cardiovascular Drug Product Introduction, Application and Specification of Bristol Myers Squibb and Pfizer
Table Cardiovascular Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bristol Myers Squibb and Pfizer Main Business
Table Bristol Myers Squibb and Pfizer Recent Development
Table Bristol Myers Squibb and Pfizer Main Business
Table Bristol Myers Squibb and Pfizer Recent Development
Table Daiichi Sankyo Company Profile
Table Cardiovascular Drug Product Introduction, Application and Specification of Daiichi Sankyo
Table Cardiovascular Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Daiichi Sankyo Main Business
Table Daiichi Sankyo Recent Development
Table Johnson & Johnson Company Profile
Table Cardiovascular Drug Product Introduction, Application and Specification of Johnson & Johnson
Table Cardiovascular Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Merck & Co. Company Profile
Table Cardiovascular Drug Product Introduction, Application and Specification of Merck & Co.
Table Cardiovascular Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck & Co. Main Business
Table Merck & Co. Recent Development
Table Novartis Company Profile
Table Cardiovascular Drug Product Introduction, Application and Specification of Novartis
Table Cardiovascular Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Pfizer Company Profile
Table Cardiovascular Drug Product Introduction, Application and Specification of Pfizer
Table Cardiovascular Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table Portola Company Profile
Table Cardiovascular Drug Product Introduction, Application and Specification of Portola
Table Cardiovascular Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Portola Main Business
Table Portola Recent Development
Table Sanofi Company Profile
Table Cardiovascular Drug Product Introduction, Application and Specification of Sanofi
Table Cardiovascular Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Main Business
Table Sanofi Recent Development
Figure Global Cardiovascular Drug Sales and Growth Rate (2017-2022)
Figure Global Cardiovascular Drug Revenue and Growth Rate (2017-2022)
Table Global Cardiovascular Drug Sales by Regions (2017-2022)
Figure Global Cardiovascular Drug Sales Market Share by Regions in 2021
Table Global Cardiovascular Drug Revenue by Regions (2017-2022)
Figure Global Cardiovascular Drug Revenue Market Share by Regions in 2021
Figure North America Cardiovascular Drug Sales and Growth Rate (2017-2022)
Figure Europe Cardiovascular Drug Sales and Growth Rate (2017-2022)
Figure China Cardiovascular Drug Sales and Growth Rate (2017-2022)
Figure Japan Cardiovascular Drug Sales and Growth Rate (2017-2022)
Figure Southeast Asia Cardiovascular Drug Sales and Growth Rate (2017-2022)
Figure Other Regions Cardiovascular Drug Sales and Growth Rate (2017-2022)
Table Global Cardiovascular Drug Sales by Big Type (2017-2022)
Table Global Cardiovascular Drug Sales Market Share by Big Type (2017-2022)
Figure Global Cardiovascular Drug Sales Market Share by Big Type in 2019
Table Global Cardiovascular Drug Revenue by Big Type (2017-2022)
Table Global Cardiovascular Drug Revenue Market Share by Big Type (2017-2022)
Table Global Cardiovascular Drug Revenue Market Share by Big Type in 2019
Figure Global heparin Sales Growth Rate (2017-2022)
Figure Global heparin Price (2017-2022)
Figure Global Coumadin Sales Growth Rate (2017-2022)
Figure Global Coumadin Price (2017-2022)
Figure Global Sectral Sales Growth Rate (2017-2022)
Figure Global Sectral Price (2017-2022)
Figure Global Zebeta Sales Growth Rate (2017-2022)
Figure Global Zebeta Price (2017-2022)
Figure Global Toprol XL Sales Growth Rate (2017-2022)
Figure Global Toprol XL Price (2017-2022)
Figure Global Norvasc Sales Growth Rate (2017-2022)
Figure Global Norvasc Price (2017-2022)
Figure Global Lotrel Sales Growth Rate (2017-2022)
Table Global Cardiovascular Drug Sales by Big Application (2017-2022)
Table Global Cardiovascular Drug Sales Market Share by Big Application (2017-2022)
Figure Global Cardiovascular Drug Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Cardiovascular Drug Sales and Growth Rate (2022-2027)
Figure Global Cardiovascular Drug Revenue and Growth Rate (2022-2027)
Table Global Cardiovascular Drug Sales Forecast by Regions (2022-2027)
Table Global Cardiovascular Drug Market Share Forecast by Regions (2022-2027)
Figure North America Sales Cardiovascular Drug Market Forecast (2022-2027)
Figure Europe Sales Cardiovascular Drug Market Forecast (2022-2027)
Figure China Sales Cardiovascular Drug Market Forecast (2022-2027)
Figure Japan Sales Cardiovascular Drug Market Forecast (2022-2027)
Figure Southeast Asia Sales Cardiovascular Drug Market Forecast (2022-2027)
Figure Other Regions Sales Cardiovascular Drug Market Forecast (2022-2027)
Table Global Cardiovascular Drug Sales Forecast by Type (2022-2027)
Table Global Cardiovascular Drug Market Share Forecast by Type (2022-2027)
Table Global Cardiovascular Drug Sales Forecast by Application (2022-2027)
Table Global Cardiovascular Drug Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cardiovascular Drug
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Cardiovascular Drug Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Cardiovascular Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Cardiovascular Drug Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Cardiovascular Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Cardiovascular Drug Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Cardiovascular Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Cardiovascular Drug Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Cardiovascular Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Amgen
AstraZeneca
Bayer
Bristol Myers Squibb and Pfizer
Daiichi Sankyo
Johnson & Johnson
Merck & Co.
Novartis
Pfizer
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)